Kawasaki Disease

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Etanercept in Kawasaki Disease
Status:
Active, not recruiting
Last Changed:
Apr 18, 2018
First Changed:
Feb 11, 2009
Disease(s):
Mucocutaneous Lymph Node Syndrome
Intervention(s):
EtanerceptPlacebo
Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease
Status:
Completed
Last Changed:
Oct 25, 2018
First Changed:
May 11, 2012
Disease(s):
Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin
Intervention(s):
TA-650Polyethylene Glycol-treated Human Immunoglobulin (VGIH)

Connect. Empower. Inspire.